Artivion | CRY - 现金及等价物



金融业
股票价格
USD
资产
USD 1.07B
现金及等价物
USD 77.32M
销售成本
USD 42.85M
流动资产
USD 371.38M
流动负债
USD 106.93M
债务
USD 317.78M
EBIT
USD 4.79M
EBITDA
USD 22.72M
员工
1.5K
EPS每股收益
USD -0.02
股本和储备
USD 445.59M
销售毛利
USD 73.14M
债务利息支出
USD 5.53M
利息收入
USD -0.05
贷款资金
USD 363.42M
市值
USD 914M
净收入
USD 2.42M
营业费用
USD 111.2M
营业利润
USD 4.79M
普通股股本
USD 47.84M
PE价格收益
212.38
税前利润
USD 11.4M
销售收入
USD 115.99M
销售和管理费用
USD 55.75M
股票
USD 103.36M
贸易债权人
USD 20.87M
应收帐款人
USD 103.68M


现金及等价物 更改 日
Abbott USD 6.8B 1.72B 2026-03
Accuray USD 41.29M 22.05M 2025-12
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 77.32M 21.55M 2026-06
AtriCure USD 167.79M 21.62M 2026-06
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Boston Scientific USD 539M 914M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Inogen USD 106.48M 2.79M 2025-09
Integra LifeSciences USD 214.42M 22.39M 2026-06
J&J USD 20.42B 1.27B 2026-06
Mesa Laboratories USD 28.98M 8.55M 2025-12
Orthofix International USD 103.81M 16.47M 2026-06
Pfizer USD 976M 727M 2026-06
ResMed USD 1.47B 191.28M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
Terumo JPY 280.49B 63.34B 2026-03
Trinity Biotech USD 5.14M 3.8M 2025-12